Comparing antifungal treatments for invasive fungal disease
Part of Infections clinical trials.
This trial studies two types of antifungal medicines (amphotericin B and azoles) to see which works better for people with invasive fungal disease. It aims to help doctors choose the safest and most effective treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with an invasive fungal disease (a serious fungal infection inside your body).
- You have received treatment with either a polyene antifungal (like amphotericin B) or an azole antifungal (like fluconazole) for at least 7 days.
- You have medical records available with enough information for the study team to review.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of antifungal medicines (liposomal amphotericin B and either isavuconazole or posaconazole) for people with blood cancers who develop a fungal infection despite taking preventive antifungal drugs. It aims to find a better treatment for these difficult infections.
This trial tests amphotericin B (an antifungal medication) in patients with blood cancers who develop a fungal infection despite already taking antifungal preventive medicine. The study aims to see if this medication can treat these hard-to-treat infections.
This trial looks at how a specific antifungal medicine, called liposomal amphotericin B, given over a longer period, helps prevent serious fungal infections in people undergoing treatment for cancer or receiving a stem cell transplant. It may be an option if you are at high risk for these infections.
This study enrolls people who have test results showing an invasive fungal infection (a fungus causing illness inside the body). The goal is to build a global registry to better understand these infections and improve future care.
This trial tests BSG005, a new IV medicine for patients with invasive fungal infections that haven't improved with standard treatment or can't use standard treatments due to side effects or resistance. The goal is to see if it's safe and effective.
This study looks at how Candida infections form biofilms (protective coatings) and resist antifungal treatments. It may help find better ways to treat serious Candida infections in people with weakened immune systems or after medical procedures.
Hear when a new Invasive Fungal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.